default author photo

Joe Yeong

Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)

1 Fusionopolis Way

#16-16 Connexis

Singapore, 138632

Singapore

SCHOLARLY PAPERS

2

DOWNLOADS

265

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Phase II Trial of Y90-Resin Microspheres Radioembolization Followed by Nivolumab in Advanced Hepatocellular Carcinoma– CA 209-678

Number of pages: 39 Posted: 01 Sep 2021
National Cancer Centre Singapore - Division of Medical Oncology, National University of Singapore (NUS) - Department of Nuclear Medicine and Molecular Imaging, National University of Singapore (NUS) - Singapore General Hospital, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, Singapore General Hospital - Nuclear Medicine and Molecular Imaging, National University of Singapore (NUS) - Singapore General Hospital, National Cancer Centre Singapore, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National University of Singapore (NUS) - Singapore General Hospital, National Cancer Centre Singapore - Division of Medical Oncology, National Cancer Centre Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, National University of Singapore (NUS) - Singapore General Hospital, National University of Singapore (NUS) - Singapore General Hospital, National University of Singapore (NUS) - Singapore General Hospital, Singapore General Hospital - Vascular and Interventional Radiology, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, National Cancer Centre Singapore - Division of Medical Oncology, National Cancer Centre Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery and National Cancer Centre Singapore - Division of Medical Oncology
Downloads 185 (409,459)

Abstract:

Loading...

Hepatocellular carcinoma, Y90-resin microspheres radioembolization, nivolumab

2.

Distinct Tumor-Resident Memory HBV-Specific T Cell Responses Correlate with Relapse-Free Survival in Patients with HBV-Associated Hepatocellular Carcinoma

Number of pages: 96 Posted: 05 Jan 2021
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, St. Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, St. Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, KK Women’s and Children’s Hospital - Department of Reproductive Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Cancer Centre Singapore - Division of Medical Oncology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University Health System (NUHS) - Division of Gastroenterology and Hepatology, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National Cancer Centre Singapore - Division of Medical Oncology and University of Washington - Department of Laboratory Medicine and Pathology
Downloads 80 (803,225)

Abstract:

Loading...